Close Menu

NEW YORK (GenomeWeb) – Quest Diagnostics today reported 2 percent year-over-year growth in its second quarter revenues, while its diagnostic information services revenues increased 3 percent.

For the three months ended June 30, overall revenues rose to $1.94 billion from $1.91 billion, matching the average analysts' estimate. Diagnostic information services grew to $1.86 billion from $1.81 billion from Q2 2016.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.